65,437 trials
Invasive Candidiasis
Primary: Number of Patients Who Develop Significant Drug-related Adverse Events. — 2; 3 Participants
Influenza
Primary: Geometric Mean Titers (GMTs) of Hemagglutination Inhibition (HI) Antibodies Before and After Fluzone® Vaccination — 5.36; 15.1; 169; 135 Titer
Gastroesophageal Reflux Disease
Primary: Percentage of Days With Neither Daytime Nor Nighttime Heartburn During Treatment as Assessed by Daily Electronic Diary-Median — 17.0; 45.7; 52.7 percentage of days…
Peripheral Neuropathy · HIV Infections
Primary: Mean Visual Analogue Scale (VAS) Pain Scores — 38.61; 30.75; 30.16; 28.95 score on scale
Esophagitis, Reflux · Esophagitis, Peptic
Primary: Percentage of Subjects With Complete Healing of Erosive Esophagitis by Week 8 as Assessed by Endoscopy - Crude Rate Analysis. — 86.9; 89.4; 84.6 percentage of subjects…
Crohn's Disease
Primary: The Number of Subjects With a Clinical Remission (Crohn's Disease Activity Index [CDAI] < 150) at Week 4 — 11; 6; 3 Particpants
Esophagitis, Reflux · Esophagitis, Peptic
Primary: Percentage of Subjects With Complete Healing of Erosive Esophagitis (EE) by Week 8 as Assessed by Endoscopy - Crude Rate Analysis. — 85.3; 85.8; 79.0 Percentage of…
Gastroesophageal Reflux Disease
Primary: Percentage of Days With Neither Daytime Nor Nighttime Heartburn During Treatment as Assessed by Daily Electronic Diary-Median — 18.5; 54.9; 50.0 percentage of days…
Gastroesophageal Reflux Disease
Primary: Percentage of Days With Neither Daytime Nor Nighttime Heartburn During Treatment as Assessed by Daily Electronic Diary-Median — 17.0; 45.7; 52.7 percentage of days…
Rhinitis, Allergic, Seasonal
Primary: Mean Change From Baseline in the Nighttime Symptom Score (NSS) — -2.3; -3.1; -2.2 Score on a Scale — p=<0.001
Major Depressive Disorder (MDD)
Primary: Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 8 — -8.4 Scores on a scale
Prostate Cancer
Primary: Number of Participants With Testosterone <=0.5 Nanogram/Milliliter From Day 28 to Day 364 — 42; 41 participants
Meningitis · Meningococcemia
Primary: Geometric Mean Titers (GMTs) of Serum Bactericidal Activity for Each of the 4 Vaccine Serogroups. — 1075.2; 193.6; 83.3; 9300.5 Titer
Non-Insulin-Dependent Diabetes Mellitus
Primary: Duration of Hyperglycaemia (>126 mg/dL) in Hours at Baseline Compared to After 12 Weeks on Treatment — 17.31; 17.53; 15.30; 10.83 Hours — p=0.064
Stomatitis · Oral Mucositis
Primary: Duration of Ulcerative Oral Mucositis — 2.3; 3.2 Days